These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27015587)

  • 1. Symptomatic Treatment of Subepithelial Infiltrates after Viral Conjunctivitis: Loteprednol or Dexamethasone?
    Koçluk Y; Sukgen EA; Cevher S; Mat E
    Ocul Immunol Inflamm; 2017 Oct; 25(5):649-653. PubMed ID: 27015587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study.
    Gouider D; Khallouli A; Maalej A; Yousfi MA; Ksiaa I; Bouguerra C; Ajili F; Khairallah M
    Cornea; 2021 Jun; 40(6):726-732. PubMed ID: 33201059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.
    Pinto RD; Lira RP; Abe RY; Zacchia RS; Felix JP; Pereira AV; Arieta CE; de Castro RS; Bonon SH
    Curr Eye Res; 2015 Sep; 40(9):870-7. PubMed ID: 25310347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial.
    Price MO; Feng MT; Scanameo A; Price FW
    Cornea; 2015 Aug; 34(8):853-8. PubMed ID: 26020827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis.
    Okumus S; Coskun E; Tatar MG; Kaydu E; Yayuspayi R; Comez A; Erbagci I; Gurler B
    BMC Ophthalmol; 2012 Aug; 12():42. PubMed ID: 22900547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis.
    Ghanem RC; Vargas JF; Ghanem VC
    Cornea; 2014 Nov; 33(11):1210-3. PubMed ID: 25188789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loteprednol Etabonate 0.5%/Tobramycin 0.3% Compared with Dexamethasone 0.1%/Tobramycin 0.3% for the Treatment of Blepharitis.
    Comstock TL; DeCory HH
    Ocul Immunol Inflamm; 2017 Apr; 25(2):267-274. PubMed ID: 26788833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.
    Jeng BH; Holsclaw DS
    Cornea; 2011 Sep; 30(9):958-61. PubMed ID: 21673568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis.
    Bhargava R; Kumar P
    Indian J Ophthalmol; 2019 May; 67(5):594-598. PubMed ID: 31007215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial comparing dexamethasone with loteprednol etabonate on postoperative photorefractive keratectomy.
    Thanathanee O; Sriphon P; Anutarapongpan O; Athikulwongse R; Thongphiew P; Rangsin R; Suwan-apichon O
    J Ocul Pharmacol Ther; 2015 Apr; 31(3):165-8. PubMed ID: 25555173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photorefractive keratectomy with mitomycin-C for the combined treatment of myopia and subepithelial infiltrates after epidemic keratoconjunctivitis.
    Alevi D; Barsam A; Kruh J; Prince J; Perry HD; Donnenfeld ED
    J Cataract Refract Surg; 2012 Jun; 38(6):1028-33. PubMed ID: 22624902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of EKC after eximer laser photorefractive surgery and subsequent recurrence of EKC-like keratitis.
    Park SJ; Jang YS; Koh TH; Kwon YA; Song SW
    Korean J Ophthalmol; 2011 Dec; 25(6):443-6. PubMed ID: 22131783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the impact of persistent subepithelial corneal infiltrations on the visual performance and corneal optical quality after epidemic keratoconjunctivitis.
    Aydin Kurna S; Altun A; Oflaz A; Karatay Arsan A
    Acta Ophthalmol; 2015 Jun; 93(4):377-82. PubMed ID: 25043311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
    Levinger E; Trivizki O; Shachar Y; Levinger S; Verssano D
    Graefes Arch Clin Exp Ophthalmol; 2014 May; 252(5):811-6. PubMed ID: 24696044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of tobramycin 0.3%/dexamethasone 0.1% and tobramycin 0.3%/loteprednol 0.5% in the management of blepharo-keratoconjunctivitis.
    Rhee SS; Mah FS
    Adv Ther; 2007; 24(1):60-7. PubMed ID: 17526462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Efficacy of Difluprednate 0.05% and Loteprednol Gel 0.5% After Cataract Surgery.
    Abessi B; Brooksby L; Schultze RL
    Eye Contact Lens; 2018 Nov; 44 Suppl 2():S37-S42. PubMed ID: 28628490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis.
    Ilyas H; Slonim CB; Braswell GR; Favetta JR; Schulman M
    Eye Contact Lens; 2004 Jan; 30(1):10-3. PubMed ID: 14722462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid.
    Comstock TL; Sheppard JD
    Expert Opin Pharmacother; 2018 Mar; 19(4):337-353. PubMed ID: 29430976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
    Pepose JS; Ahuja A; Liu W; Narvekar A; Haque R
    Am J Ophthalmol; 2018 Oct; 194():7-15. PubMed ID: 29787732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemic keratoconjunctivitis: treatment results during an epidemic].
    Hutter H
    Klin Monbl Augenheilkd; 1990 Sep; 197(3):214-7. PubMed ID: 1701507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.